Status:
UNKNOWN
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Skin Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is to evaluate the psychological well-being in patients diagnosed with skin cancer (melanoma and Squamous Cell Carcinoma (SCC) in the face) at the time of diagnosis and after treatment. Pat...
Eligibility Criteria
Inclusion
- individuals diagnosed with melanoma, SCC and/or infiltrative basal cell carcinoma on the face for surgical treatment and planned for excision or Mohs surgery
- patients who are able to give informed consent
Exclusion
- Electrodesication and curettage of the tumour
Key Trial Info
Start Date :
November 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04485442
Start Date
November 9 2020
End Date
August 1 2024
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Plastic, Reconstructive and Aesthetic Surgery and Department of Dermatology , University Hospital Basel
Basel, Switzerland, 4031